MedTrace Logo

Conservative Management of Placenta Accreta Spectrum Using Kasr Al-Ainy Technique With or Without Hayman Sutures

NCT07519993 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-04-09

No results posted yet for this study

Summary

This study evaluates whether adding Hayman sutures in the conservative Management of Placenta Accreta Spectrum Using Kasr Al-Ainy Technique reduces intraoperative blood loss and improves outcomes

Conditions

  • Placenta Accreta Spectrum

Interventions

PROCEDURE

Kasr Al-Ainy Technique Alone

1. Vascular Ligation: Bilateral uterine artery tying at high and low levels. 2. Compression Sutures: Anterior and posterior cervicovaginal stitches for hemostasis. 3. Segmental Resection: Excision of invaded myometrium and placental tissue. 4. Dual-Layer Repair: Myometrial approximation followed by reinforcing imbricating sutures. 5. Final Hemostasis: Confirmation of bleeding control prior to abdominal closure.

PROCEDURE

Kasr Al-Ainy Technique + Hayman Sutures

1. Vascular Ligation: Bilateral uterine artery tying at high and low levels. 2. Compression Sutures: Anterior and posterior cervicovaginal stitches for hemostasis. 3. Segmental Resection: Excision of invaded myometrium and placental tissue. 4. Dual-Layer Repair: Myometrial approximation followed by reinforcing imbricating sutures. 5. Final Hemostasis: Confirmation of bleeding control prior to abdominal closure. 6. Application of Hayman vertical compression sutures

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Emad Salah, M.D. · Cairo University

  • Mona Sedik, M.D. · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-05
Primary Completion
2026-12-31
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07519993 on ClinicalTrials.gov